Cochrane Review Group
Tobacco Addiction
68 systematic reviews in Tobacco Addiction ask 430 questions. 6% have no studies to answer them, 27% rest on very low certainty evidence and 27.2% reach moderate or high certainty.
Reviews
68
Questions
430
current versions
No studies
6%
Moderate or high
27.2%
No studies 26 · 6%Ungraded 12 · 2.8%Very low 116 · 27%Low 159 · 37%Moderate 87 · 20.2%High 30 · 7%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Smoking cessation counselling vs no smoking cessation counselling, grouped by intensity of intervention Quit at longest · individuals who smoke cigarettes and are admitted to a hospital for medical or surgical care Interventions for smoking cessation in hospitalised patients (2024) · Cochrane | RR 1.52 [0.8, 2.89] | 2 studies · 1417 participants | Very low |
Telephone quitline referral vs no treatment or usual care Quitline referral vs control · smoking cessation in hospitalised patients Interventions for smoking cessation in hospitalised patients (2024) · Cochrane | RR 1.17 [0.7, 1.96] | 2 studies · 1870 participants | Very low |
Telephone quitline referral vs no treatment or usual care Health system telephone counselling vs quitline · smoking cessation in hospitalised patients Interventions for smoking cessation in hospitalised patients (2024) · Cochrane | RR 1.23 [1, 1.51] | 3 studies · 3260 participants | Very low |
Smoking cessation counselling vs no smoking cessation counselling, grouped by intensity of intervention Quit at longest · individuals who smoke cigarettes and are admitted to a hospital for medical or surgical care Interventions for smoking cessation in hospitalised patients (2024) · Cochrane | RR 1.04 [0.9, 1.2] | 7 studies · 4627 participants | Very low |
Hospital‐only intervention vs intervention that continues after hospital discharge Behavioural support ‐ asynchronous** · smoking cessation in hospitalised patients Interventions for smoking cessation in hospitalised patients (2024) · Cochrane | RR 0.97 [0.83, 1.14] | 2 studies · 1598 participants | Very low |
Nicotine EC vs behavioural support only/no support Serious adverse events at 4 weeks to 8 months Assessed via self‐report and medical records · People who smoke Electronic cigarettes for smoking cessation (2024) · Cochrane | RR 0.89 [0.59, 1.34] | 10 studies · 3263 participants | Very low |
Intervention NR Bupropion therapy plus behavioral intervention vs behavioral intervention alone (continuous waterpipe smoking abstinence, defined as an expired CO of 9 ppm or less at the 6‐month postintervention · people who use waterpipe Interventions for waterpipe smoking cessation (2023) · Cochrane | RR 0.77 [0.42, 1.41] | 121 participants | Very low |
Intervention NR Bupropion therapy plus behavioral support versus self‐help (continuous waterpipe smoking abstinence, defined as an expired CO of 9 ppm or less at the 6‐month postintervention · people who use waterpipe Interventions for waterpipe smoking cessation (2023) · Cochrane | RR 1.94 [0.94, 4] | 86 participants | Very low |
Intervention NR E‐health interventions · people who use waterpipe Interventions for waterpipe smoking cessation (2023) · Cochrane | OR 1.48 | 2 studies · 389 participants | Very low |
Cytisine vs varenicline Neuropsychiatric SAEs · people who smoke tobacco Nicotine receptor partial agonists for smoking cessation (2023) · Cochrane | no estimate extracted | NR | No studies |
Cytisine vs varenicline Cardiac SAEs · people who smoke tobacco Nicotine receptor partial agonists for smoking cessation (2023) · Cochrane | no estimate extracted | NR | No studies |
Cytisine vs nicotine replacement therapy SAEs · people who smoke tobacco Nicotine receptor partial agonists for smoking cessation (2023) · Cochrane | RR 1.15 [0.76, 1.75] | 1 study · 1310 participants | Very low |
Reviews 68
Interventions for smoking cessation in hospitalised patients
CochraneSoF table
12 questions
Electronic cigarettes for smoking cessation
CochraneSoF table
9 questions
Antidepressants for smoking cessation
CochraneSoF table
9 questions
Interventions for waterpipe smoking cessation
CochraneSoF table
5 questions
Nicotine receptor partial agonists for smoking cessation
CochraneSoF table
32 questions
Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation
CochraneSoF table
30 questions
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta‐analyses
CochraneSoF table
19 questions
Mindfulness for smoking cessation
CochraneSoF table
15 questions
Heated tobacco products for smoking cessation and reducing smoking prevalence
CochraneSoF table
15 questions
Smoking cessation for secondary prevention of cardiovascular disease
CochraneSoF table
2 questions
Interventions for tobacco cessation delivered by dental professionals
CochraneSoF table
4 questions
Interventions for preventing weight gain after smoking cessation
CochraneSoF table
25 questions
Strategies to improve smoking cessation rates in primary care
CochraneSoF table
8 questions
Serum or plasma ferritin concentration as an index of iron deficiency and overload
CochraneSoF table
12 questions
Smoking cessation for improving mental health
CochraneSoF table
3 questions
Whole‐cell pertussis vaccine in early infancy for the prevention of allergy in children
CochraneSoF table
6 questions
Pharmacological interventions for promoting smoking cessation during pregnancy
CochraneSoF table
6 questions
Interventions to reduce tobacco use in people experiencing homelessness
CochraneSoF table
3 questions
Hypnotherapy for smoking cessation
CochraneSoF table
4 questions
Print‐based self‐help interventions for smoking cessation
CochraneSoF table
2 questions
Exercise interventions for smoking cessation
CochraneSoF table
2 questions
Telephone counselling for smoking cessation
CochraneSoF table
2 questions
Community pharmacy personnel interventions for smoking cessation
CochraneSoF table
1 questions
Relapse prevention interventions for smoking cessation
CochraneSoF table
5 questions
Incentives for smoking cessation
CochraneSoF table
2 questions